This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The General Hospital Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Stefan Pinter
Introduction
Stefan Pinter is a notable inventor based in Cambridge, MA. He has made significant contributions to the field of genetics, particularly in the area of gene reactivation. His work focuses on addressing X-linked diseases, which affect many individuals worldwide.
Latest Patents
Stefan Pinter holds a patent titled "Methods and compositions for selectively reactivating genes on the inactive X chromosome (Xi) in a locus-specific manner." This innovative approach aims to selectively reactivate genes associated with various X-linked diseases, including Rett Syndrome, Factor VIII or IX deficiency, Fragile X Syndrome, Duchenne muscular dystrophy, and Paroxysmal Nocturnal Hemoglobinuria (PNH) in heterozygous females. He has 1 patent to his name.
Career Highlights
Stefan Pinter is affiliated with The General Hospital Corporation, where he continues to advance his research and innovations. His work has the potential to transform the treatment of genetic disorders, providing hope for many affected individuals.
Collaborations
Stefan collaborates with esteemed colleagues, including Jeannie T Lee and Ruslan Sadreyev. Their combined expertise enhances the impact of their research and fosters innovation in the field.
Conclusion
Stefan Pinter's contributions to genetics and his innovative patent on gene reactivation highlight his role as a leading inventor in the field. His work not only advances scientific understanding but also offers potential solutions for those affected by X-linked diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile